Research Topics

Sibu P Saha

Summary

Affiliation: University of Kentucky
Country: USA

Publications

  1. ncbi Solitary fibrous tumor of the pleura
    Sibu P Saha
    Department of Surgery, University of Kentucky, Lexington, USA
    Int Surg 92:351-4. 2007
  2. ncbi Intraoperative evaluation of revascularization effect on ischemic muscle hemodynamics using near-infrared diffuse optical spectroscopies
    Guoqiang Yu
    University of Kentucky, Center for Biomedical Engineering, Lexington, Kentucky 40506 0070, USA
    J Biomed Opt 16:027004. 2011
  3. ncbi Current management of peripheral vascular disease: where is the evidence?
    Sibu P Saha
    Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, KY 40536, USA
    Cardiovasc Hematol Agents Med Chem 9:128-36. 2011

Collaborators

  • Guoqiang Yu
  • Yu Shang
  • Youquan Zhao
  • Ran Cheng
  • Lixin Dong

Detail Information

Publications3

  1. ncbi Solitary fibrous tumor of the pleura
    Sibu P Saha
    Department of Surgery, University of Kentucky, Lexington, USA
    Int Surg 92:351-4. 2007
    ..0 cm. All were resected by thoracotomy. The largest of these tumors weighed 68 g. All patients remain disease free. Follow-up ranged from 2 to 20 years. This is a rare disease. Complete resection offers the best chance for long-term care...
  2. ncbi Intraoperative evaluation of revascularization effect on ischemic muscle hemodynamics using near-infrared diffuse optical spectroscopies
    Guoqiang Yu
    University of Kentucky, Center for Biomedical Engineering, Lexington, Kentucky 40506 0070, USA
    J Biomed Opt 16:027004. 2011
    ..In total, the investigation corroborates potential of the optical methods for objectively assessing the success of arterial revascularization...
  3. ncbi Current management of peripheral vascular disease: where is the evidence?
    Sibu P Saha
    Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, KY 40536, USA
    Cardiovasc Hematol Agents Med Chem 9:128-36. 2011
    ..It has been shown that these patients are undertreated in spite of their high cardiovascular risk. It is mandatory that they receive the same intensive treatment of risk factors as that given to coronary heart disease patients...